{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:19Z","timestamp":1740115039391,"version":"3.37.3"},"reference-count":18,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011893","name":"Pan American Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vaccine.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T05:26:13Z","timestamp":1715750773000},"page":"3851-3856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0804-939X","authenticated-orcid":false,"given":"Cinthya","family":"Urquidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-0882","authenticated-orcid":false,"given":"Alejandro","family":"Sep\u00falveda-Pe\u00f1aloza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda T.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3653-6460","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Menares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-9783","authenticated-orcid":false,"given":"Claudia P.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4931-6362","authenticated-orcid":false,"given":"Rosana","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Santelices","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-8365","authenticated-orcid":false,"given":"Renato","family":"Anfossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Moller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-002X","authenticated-orcid":false,"given":"Mar\u00eda E.","family":"Santolaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2024.05.002_b0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0264-410X(90)90042-K","article-title":"Role of epidemiology in vaccine policy","volume":"8","author":"Begg","year":"1990","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.002_b0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.002_b0015","first-page":"488","article-title":"Methodological issues of confounding in analytical epidemiologic studies","volume":"3","author":"Hajian","year":"2012","journal-title":"Caspian J Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.002_b0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ije\/dym021","article-title":"Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness","volume":"36","author":"Orenstein","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.002_b0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/EDE.0000000000001116","article-title":"The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology","volume":"31","author":"Chua","year":"2020","journal-title":"Epidemiology"},{"issue":"37","key":"10.1016\/j.vaccine.2024.05.002_b0030","doi-asserted-by":"crossref","first-page":"20585","DOI":"10.2807\/1560-7917.ES2013.18.37.20585","article-title":"The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials","volume":"18","author":"Serres","year":"2013","journal-title":"Eurosurveillance"},{"issue":"6","key":"10.1016\/j.vaccine.2024.05.002_b0035","first-page":"2052","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings","volume":"45","author":"Foppa","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"33","key":"10.1016\/j.vaccine.2024.05.002_b0040","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.vaccine.2018.06.072","article-title":"A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness","volume":"36","author":"Haber","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.002_b0045","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12879-017-2838-2","article-title":"A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination","volume":"17","author":"Shi","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.002_b0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/EDE.0000000000001366","article-title":"Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines","volume":"32","author":"Lewnard","year":"2021","journal-title":"Epidemiology"},{"issue":"48","key":"10.1016\/j.vaccine.2024.05.002_b0055","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1016\/j.vaccine.2022.10.034","article-title":"Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States","volume":"40","author":"Turbyfill","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.002_b0060","unstructured":"Secci\u00f3n Gesti\u00f3n de la Informaci\u00f3n - ANDID, Instituto de Salud P\u00fablica: Ministerio de Salud, Gobierno de Chile. Vigilancia Gen\u00f3mica SARS-Cov2 ISP. https:\/\/vigilancia.ispch.gob.cl\/app\/varcovid [accessed July 26 2022]."},{"key":"10.1016\/j.vaccine.2024.05.002_b0065","unstructured":"Our World in Data. https:\/\/ourworldindata.org\/covid-vaccinations [accessed 18 September 2022]."},{"key":"10.1016\/j.vaccine.2024.05.002_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2023.100474","article-title":"The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case\u2013control study","author":"Kahn","year":"2023","journal-title":"Lancet Regional Health \u2013 Americas [Internet]"},{"key":"10.1016\/j.vaccine.2024.05.002_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h391","article-title":"The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting","volume":"350","author":"Hemming","year":"2015","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.vaccine.2024.05.002_b0080","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.vaccine.2023.03.060","article-title":"The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study","volume":"41","author":"Urquidi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.002_b0085","unstructured":"Evaluaci\u00f3n de la efectividad de la vacuna contra la COVID-19 en Chile, 2021 - PAHO\/WHO | Pan American Health Organization [Internet]. [citado 2 de agosto de 2023]. Disponible en: https:\/\/www.paho.org\/node\/86651."},{"issue":"10","key":"10.1016\/j.vaccine.2024.05.002_b0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T11:26:21Z","timestamp":1718018781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":18,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0264410X24005383"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}